洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR2000038827】Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic

查看原文

立即下载

基本信息

登记号

ChiCTR2000038827

试验状态

尚未开始

药物名称

药物类型

规范名称

首次公示信息日的期

2020-10-05

临床申请受理号

靶点

适应症

2-10 children with autism spectrum disorder or attention deficit/hyperactivity disorder

试验通俗题目

Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic

试验专业题目

Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

To design a multicomponent online health intervention for children with special educational need (SEN) and their families during the COVID-19 pandemic. To evaluate the effectiveness of the online intervention in improving overall well-being in both children and parents and reducing parenting stress and increasing childrens healthy lifestyle behaviours.

试验分类

请登录查看

试验类型

单臂

试验分期

其它

随机化

N/A

盲法

N/A

试验项目经费来源

香港賽馬會慈善信託基金

试验范围

目标入组人数

1500

实际入组人数

第一例入组时间

2020-11-02

试验终止时间

2021-12-02

是否属于一致性

入选标准

(1) Children aged 2-10 years who have been previously diagnosed with ASD or ADHD or both by a doctor/psychologist according to the Diagnostic and Statistical Manual of Mental Disorders-4/5 (DSM-4/5) diagnostic criteria; (2) and at least one of their parents agrees to participate.；

排除标准

(1) Being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese, (2) having a medical condition rendering him/her to be incapable to participate in the study; (3) unwilling or unable to give consent.；

研究者信息

研究负责人姓名

请登录查看

试验机构

香港賽馬會慈善信託基金

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看